| Literature DB >> 33679794 |
Anne Marit Sponaas1, Anders Waage1,2, Esten N Vandsemb1, Kristine Misund1, Magne Børset1,3, Anders Sundan1, Tobias Schmidt Slørdahl1,2, Therese Standal1,4.
Abstract
In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy.Entities:
Keywords: T cells; checkpoint therapy; immunomodulating drugs; multiple myeloma; virus
Year: 2021 PMID: 33679794 PMCID: PMC7928324 DOI: 10.3389/fimmu.2021.636375
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561